ClinicalTrials.gg
Drug

Pyranoprofen clinical trials

studies test it
3
open now
0
in phase 3
0
first study started
2011

How each study uses pyranoprofen is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Other names

Pranoprofen
1
zaltoprofen
1

Studies by the year they started

3 studies that test it; most in 2011 (1)

Studies that test pyranoprofen, by start year
YearStudies
20111
20161
20241

By phase

A phase 1/2 study counts in both.

Phase 4
1
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 0 · Other 3

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1) · Università degli Studi di Brescia (1) · Korean Pharmacoacupuncture Institute (1)

Often tested with

Tested in the same studies.

Prednisolone (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses pyranoprofen is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 3

Codes

What other systems call pyranoprofen · ClinicalTrials.gg INT003182

  • MeSH (NLM) C043940pyranoprofenConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 2R7O1ET613PRANOPROFENConfirmed FDA, NLM

Also registered as zaltoprofen (UNII H8635NG3PY).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.